We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Articles

Results 1 to 5 of 8
Most popular |Most recent


FLH Successfully Defends Shire’s Patents Covering Blockbuster Drug Vyvanse

USA - August 30 2016 On August 30, 2016, Judge Stanley R. Chesler of the U.S. District Court for the District of New Jersey entered a Final Judgment ending a Hatch-Waxman...

David A. Zwally, Edgar H. Haug, Porter F. Fleming, Sandra Kuzmich, Angus Chen.

En Banc Federal Circuit Affirms That Contract Manufacturer’s Services Do Not Trigger the On-Sale Bar for FLH Client The Medicines Company

USA - July 11 2016 On July 11, 2016, the U.S. Court of Appeals for the Federal Circuitsitting en bancissued a unanimous decision in The Medicines Company v. Hospira...

Robert E. Colletti, Richard F. Kurz, Edgar H. Haug, Porter F. Fleming, Angus Chen.

Again, FLH Successfully Defends Shire’s Lialda Patent at Trial

USA - March 28 2016 On March 25, 2016, Judge Donald M. Middlebrooks of the U.S. District Court for the Southern District of Florida ruled that the patent protecting...

Erika V. Selli, Andrew Wasson, Elizabeth Murphy, Edgar H. Haug, Caroline Bercier.

En banc Federal Circuit to consider whether a contract manufacturer’s services trigger the on-sale bar for FLH client The Medicines Company

USA - November 13 2015 On November 13, 2015, the U.S. Court of Appeals for the Federal Circuit granted a petition for rehearing en banc filed by Frommer Lawrence & Haug LLP...

David A. Zwally, Richard F. Kurz, Edgar H. Haug, Porter F. Fleming, Angus Chen.

Generic competitor’s regulatory issues prompt stay of Lialda patent litigation

USA - August 13 2015 In a first-of-its-kind public decision, Frommer Lawrence & Haug LLP obtained a stay and administrative closure of a Hatch-Waxman patent case on...

Andrew Wasson, Elizabeth Murphy, Edgar H. Haug.